drugset / Trial / NCT00134498

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

NCT00134498

Phase 3 Completed 160 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To assess the safety and efficacy of the fixed combination torcetrapib/atorvastatin in subjects with Fredrickson Type IV Hypertriglyceridemia.

Timeline

Start
2005-02
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule Oral
Subject torcetrapib Small molecule Oral